Preferential selectivity of inhibitors with human tau protein kinase Gsk3 β elucidates their potential roles for off-target Alzheimer's therapy

International Journal of Alzheimer's Disease

Volumn 2013, Issue , 2013, Pages

  Kumar Dasappa, Jagadeesh ^a   Nagendra, H G ^a  

^a SIR M VISVESVARAYA INSTITUTE OF TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPYRROLIDINE; ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; CASEIN KINASE IDELTA; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE 5; DUAL SPECIFICITY TYROSINE PHOSPHORYLATION REGULATED KINASE 1A; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 10; MITOGEN ACTIVATED PROTEIN KINASE P38; MOLECULAR SCAFFOLD; PROTEIN KINASE B; PROTEIN KINASE C ALPHA; PROTEIN KINASE INHIBITOR; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CATALYSIS; DEMENTIA; DRUG TARGETING; ENZYME ACTIVE SITE; ENZYME STRUCTURE; HUMAN; MOLECULAR DOCKING; NERVE CELL; NEUROFIBRILLARY TANGLE; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN DATA BANK; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SEQUENCE ALIGNMENT; SYNAPSE;

EID: 84886643413     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.1155/2013/809386     Document Type: Article

References (14)

1. Hemming M. L., Elias J. E., Gygi S. P., Selkoe D. J., Identification of beta-secretase (BACE1) substrates using quantitative proteomics. PloS ONE 2009 4 12 e8477 2-s2.0-77949533331
2. Selkoe D. J., Amyloid β -protein and the genetics of Alzheimer's disease. The Journal of Biological Chemistry 1996 271 31 18295 18298 2-s2.0-0029784838 (Pubitemid 26322675)
3. Selkoe D. J., Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nature Cell Biology 2004 6 11 1054 1061 2-s2.0-7944233158 10.1038/ncb1104-1054 (Pubitemid 39468006)
4. Iqbal K., Liu F., Gong C.-X., Grundke-Iqbal I., Tau in Alzheimer disease and related tauopathies. Current Alzheimer Research 2010 7 8 656 664 2-s2.0-79951766324
5. Martina L., Latypovac X., Wilsona C. M., Magnaudeixa A., Perrina M. -L., Yardina C., Terroa F., Tau protein kinases: involvement in Alzheimer's disease. Ageing Research Reviews 2013 12 1 289 309
6. Chung S.-H., Aberrant phosphorylation in the pathogenesis of Alzheimer's disease. BMB Reports 2009 42 8 467 474 2-s2.0-70349570600
7. Ferrer I., Gomez-Isla T., Puig B., Freixes M., Ribé E., Dalfó E., Avila J., Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies. Current Alzheimer Research 2005 2 1 3 18 2-s2.0-25844458239 10.2174/ 1567205052772713 (Pubitemid 41389255)
8. Aoki M., Yokota T., Sugiura I., Sasaki C., Hasegawa T., Okumura C., Ishiguro K., Kohno T., Sugio S., Matsuzaki T., Structural insight into nucleotide recognition in tau-protein kinase I/glycogen synthase kinase 3 β Acta Crystallographica D 2004 60 3 439 446 2-s2.0-7444248951 10.1107/S090744490302938X (Pubitemid 41087571)
9. Ji W., Ha I., Drug development for Alzheimer's disease: recent progress. Experimental Neurology 2010 19 3 120 131 10.5607/en.2010.19.3.120
10. Liu F., Liang Z., Shi J., Yin D., El-Akkad E., Grundke-Iqbal I., Iqbal K., Gong C.-X., PKA modulates GSK-3 β-and cdk5-catalyzed phosphorylation of tau in site- and kinase-specific manners. FEBS Letters 2006 580 26 6269 6274 2-s2.0-33750510335 10.1016/j.febslet.2006.10.033 (Pubitemid 44666812)
11. Martinez A., Gil C., Perez D. I., Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatment. International Journal of Alzheimer's Disease 2011 2011 7 2-s2.0-80052658723 10.4061/2011/280502 280502
12. http://www.ebi.ac.uk/Tools/phylogeny/clustalw2-phylogeny/
13. Corpet F., Multiple sequence alignment with hierarchical clustering. Nucleic Acids Research 1988 16 22 10881 10890 2-s2.0-0024297354 10.1093/nar/16.22.10881
14. Shatsky M., Nussinov R., Wolfson H. J., A method for simultaneous alignment of multiple protein structures. Proteins 2004 56 1 143 156 2-s2.0-2442456104 10.1002/prot.10628 (Pubitemid 38720846)